Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-25-000063
Filing Date
2025-11-07
Accepted
2025-11-07 16:04:41
Documents
77
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20250930.htm   iXBRL 10-Q 1603488
2 EX-19.1 exhibit191_insidertradingc.htm EX-19.1 105034
3 EX-31.1 lgnd_93025exhibit311.htm EX-31.1 15007
4 EX-31.2 lgnd_93025exhibit312.htm EX-31.2 15277
5 EX-32.1 lgnd_93025exhibit321.htm EX-32.1 11054
11 LIGAND LOGO lgnd-20250930_g1.jpg GRAPHIC 43732
  Complete submission text file 0000886163-25-000063.txt   10384771

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20250930.xsd EX-101.SCH 69743
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20250930_cal.xml EX-101.CAL 112664
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20250930_def.xml EX-101.DEF 482705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20250930_lab.xml EX-101.LAB 947035
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20250930_pre.xml EX-101.PRE 675114
80 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20250930_htm.xml XML 1434733
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 251462550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)